PCM
EW icon

Peregrine Capital Management’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-405,261
Closed -$26.7M 341
2024
Q3
$26.7M Sell
405,261
-3,888
-1% -$257K 0.81% 24
2024
Q2
$37.8M Buy
409,149
+8,076
+2% +$746K 1.1% 19
2024
Q1
$38.3M Sell
401,073
-6,756
-2% -$646K 1.1% 19
2023
Q4
$31.1M Sell
407,829
-15,814
-4% -$1.21M 0.93% 24
2023
Q3
$29.3M Buy
423,643
+112
+0% +$7.76K 0.88% 23
2023
Q2
$40M Sell
423,531
-4,675
-1% -$441K 1.09% 18
2023
Q1
$35.4M Buy
428,206
+5,122
+1% +$424K 1.02% 17
2022
Q4
$31.6M Buy
423,084
+6,485
+2% +$484K 0.99% 14
2022
Q3
$34.4M Sell
416,599
-5,789
-1% -$478K 1.11% 12
2022
Q2
$40.2M Sell
422,388
-25,467
-6% -$2.42M 1.21% 9
2022
Q1
$52.7M Sell
447,855
-37,938
-8% -$4.47M 1.25% 10
2021
Q4
$62.9M Buy
485,793
+41,643
+9% +$5.39M 1.26% 15
2021
Q3
$50.3M Sell
444,150
-3,428
-0.8% -$388K 1.04% 19
2021
Q2
$46.4M Buy
447,578
+20,564
+5% +$2.13M 0.83% 23
2021
Q1
$35.7M Buy
427,014
+29,871
+8% +$2.5M 0.66% 28
2020
Q4
$36.2M Buy
397,143
+50,687
+15% +$4.62M 0.69% 32
2020
Q3
$27.7M Buy
346,456
+70,823
+26% +$5.65M 0.73% 31
2020
Q2
$19M Buy
275,633
+186,671
+210% +$12.9M 0.54% 62
2020
Q1
$16.8M Buy
88,962
+697
+0.8% +$131K 0.6% 58
2019
Q4
$20.6M Buy
88,265
+331
+0.4% +$77.2K 0.52% 67
2019
Q3
$19.3M Sell
87,934
-16,924
-16% -$3.72M 0.53% 76
2019
Q2
$19.4M Hold
104,858
0.48% 82
2019
Q1
$20.1M Buy
104,858
+1,240
+1% +$237K 0.5% 75
2018
Q4
$15.9M Buy
103,618
+2,580
+3% +$395K 0.45% 90
2018
Q3
$17.6M Hold
101,038
0.42% 110
2018
Q2
$14.7M Buy
101,038
+330
+0.3% +$48K 0.37% 123
2018
Q1
$14.1M Sell
100,708
-378
-0.4% -$52.7K 0.34% 121
2017
Q4
$11.4M Hold
101,086
0.27% 145
2017
Q3
$11.1M Hold
101,086
0.27% 154
2017
Q2
$12M Hold
101,086
0.3% 138
2017
Q1
$9.54M Sell
101,086
-32,381
-24% -$3.06M 0.24% 175
2016
Q4
$12.5M Buy
+133,467
New +$12.5M 0.32% 122